Novartis hits pause on Fovista agreement

Novartis hits pause on Fovista agreement Dive Brief: Novartis and Ophthotech Corp. have suspended big pieces of a licensing agreement for the latter company’s lead candidate until the drug can prove its effectiveness in late-stage… read more →